Laserfiche WebLink
S++ate of California -Health and Human Services cy Department of Health Services <br />�?ape_1 of 4 pages <br />RADIOACTIVE <br /> fagri�ve Material, and <br />in reliance on statements and representations heretofore made by the licensee, a license is hereby issued o i tt� nsee to receive, <br />use, possess, transfer, or dispose of radioactive material listed below; and to use such radloactiv nal for the purpose(s) and at the <br />places(s) designated below. This license is subject to all applicable rules, regulations, and orders o I #J'Pf,It,!aft ervfces now <br />or hereafter in effect and to any standard or specific condition specified in this license. PEP) P0, "T + � rt f. <br />ES <br />Kaiser Permanente Medical Facility <br />2. Address: 7373 West Lane <br />Stockton, CA 95210 <br />Attention: Michael D. Reitz, M.D. <br />Radiation Safety Officer <br />License Number 5766-39 is hereby amended as follows: <br />3. License <br />ber., <br />5766-39 <br />Amendment Number. 15 <br />4. Expiration date: <br />July 22, 2012 (3) <br />5. Inspection agency: Radiologic Health Branch <br />Sacrnmentn <br />6. Nuclide <br />7. Form <br />8. Possession Limit <br />A. Groups 1, 2, 3 and 4 as specified <br />A. Any <br />A. Combined possession limit for <br />in Item 9. Any radionuclide with <br />Excluding Xenon <br />Groups 1, 2, 3 and 4 not to exceed <br />atomic numbers 3-83. <br />Excluding generators <br />1 Ci. <br />B. Group 9 as specified in Item 9. <br />B. Sealed or solid sources <br />B. Total not to exceed 25 mCi. <br />Any radionuclide with atomic <br />manufactured in accordance with a <br />Each source not to exceed <br />numbers 3-83,'inclusive, except: <br />specific license issued by the <br />13 mCi. <br />Strontium -90 and Lead -210. <br />United States Nuclear Regulatory <br />Commission, an Agreement State <br />or a Licensing State. <br />9. Authorized Use <br />To be used for nuclear medicine procedures as specified in groups below: <br />A. Group 1 Diagnostic studies involving measurement of uptake, dilution, or excretion but not involving <br />imaging. <br />Group 2 Diagnostic studies involving imaging excluding the use of Xenon -127 and/or Xenon -133 gas. <br />Group 3 Reagent kits for preparation of radiopharmaceuticals listed in Group 2. <br />Group 4 Internal therapy and palliative treatment not usually requiring hospitalization. <br />B. Group 9 Marker and calibration sources. <br />LICENSE CONDITIONS <br />10. Radioactive material shall be used only at the following location: <br />(a) 7373 West Lane, Stockton, CA. <br />